
MiNK Therapeutics (INKT) Earnings Dates & Reports
MiNK Therapeutics (INKT) Most Recent Earnings
Report Date
Period EndingQ3 2025
Est. EPS-$0.86
Actual EPS-$0.65
EarningsBeat
MiNK Therapeutics (INKT) Earnings
View the latest MiNK Therapeutics (INKT) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in MiNK Therapeutics (INKT)
Order type
Buy in
Order amount
Est. shares
0 shares
MiNK Therapeutics (INKT) Earnings per Share (EPS) History
Signup for full accessBrowse free
MiNK Therapeutics (INKT) Latest Earnings
The value each INKT share was expected to gain vs. the value each share gained.
MiNK Therapeutics (INKT) reported its most recent earnings on for Q3 2025, posting earnings per share (EPS) of -$0.65. This exceeded analysts' expectations of -$0.86 by 24.42%, marking a Beat.
For comparison, MiNK Therapeutics reported EPS of -$0.50 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.74.
MiNK Therapeutics (INKT) Earnings History
MiNK Therapeutics (INKT) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the MiNK Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
MiNK Therapeutics (INKT) Earnings FAQs
MiNK Therapeutics (INKT) last reported earnings on Nov 14, 2025 for Q3 2025, posting an EPS of -$0.65, which Beat the estimate of -$0.86 by 24.42%.
For Q3 2025, MiNK Therapeutics (INKT) reported an EPS of -$0.65, exceeding analysts' estimate of -$0.86 by 24.42%.
For Q3 2025, MiNK Therapeutics (INKT) Beat expectations with an actual EPS of -$0.65 vs. an estimated EPS of -$0.86.
Following the last earnings report on Nov 14, 2025, MiNK Therapeutics (INKT)'s stock price moved — from — to —.
The next MiNK Therapeutics (INKT) earnings call is scheduled for Mar. 17, 2026, where executives will discuss financial results and outlook.